☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Celltrion
Celltrion’s Yuflyma (Biosimilar, Humira) Receives the US FDA’s Interchangeability Designation
April 15, 2025
Celltrion Launches Remdantry (Biosimilar, Remicade) Across Canada
March 27, 2025
Celltrion's Steqeyma (Biosimilar, Stelara) Adds into the Costco Member Prescription Program
March 27, 2025
Celltrion launches SteQeyma (Biosimilar, Stelara) in the US
March 13, 2025
Celltrion’s Omlyclo (Biosimilar, Xolair) Secures the US FDA’s Approval
March 10, 2025
Celltrion Reports the US FDA approval for Stoboclo & Osenvelt (Biosimilars, Prolia & Xgeva)
March 5, 2025
Load more...
Back to Home
Modal title
×
Modal body text goes here.